Lupin secures a tentative approval from the USFDA further expanding India as the global leader in the pharmaceutical industry the drug actively blocks testosterone from stimulating cancer cell growth
Alembic Pharma has gained entry into the USD 27 million US flu drug market after receiving USFDA approval for its generic flu drug, Oseltamivir Phosphate for Oral Suspension.
India gets a rare end-to-end ADC manufacturing facility as Shilpa Biologicals, a material subsidiary of Shilpa Medicare, commissioned one of the country’s few fully integrated Antibody-Drug Conjugate (ADC) manufacturing plants.
India may be preparing for a major shift in its healthcare access as the government looks to accelerate medical devices manufacturing India and reduce the country's dependence on imported equipment.
Sun Pharma’s latest acquisition marks another strategic step in its efforts to strengthen its presence beyond traditional pharmaceuticals.
In an insightful discussion on “Building a Strong MedTech Ecosystem” with Thiruamuthan, Assistant Editor at India Pharma Outlook, Dr. Rajiv Chhibber, Joint Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), shares his perspecti
Lupin enters hypertension drug market as it announced the commercial launch of Azilsartan Medoxomil tablets in the United States.
.jpeg)
Neuland’s $20M facility in Hyderabad strengthens Genome Valley’s position as a leading pharma innovation hub focused on advanced drug development.
Kiran Mazumdar-Shaw is placing one of Biocon's biggest bets on a market many pharmaceutical companies are no longer prioritizing. As global drugmakers rush to capitalize on the booming demand for GLP-1 and obesity drugs, the Biocon...
India’s respiratory disease surge is creating massive demand for treatments, and pharma companies are moving fast to meet it.
.jpg)
, CDSCO.jpg)